Crossmark

The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents

Published Online: 2018-08-24

Published Print: 2019-02-14

Authors

Darrow, Jonathan J. https://orcid.org/0000-0002-7351-4243
Beall, Reed F.

Kesselheim, Aaron S.
Funding

Funding for this research was provided by:

Laura and John Arnold Foundation (117077)
License Information

Text and Data Mining valid from 2018-08-24

Version of Record valid from 2018-08-24
More Information

Article History

First Online: 24 August 2018

Change Date: 10 December 2025

Change Type: Update

Change Details: The original online version of this article was revised to include the supplementary material.

Compliance with Ethical Standards

: Work on this project at the Program on Regulation, Therapeutics, and Law (PORTAL) was supported by the Laura and John Arnold Foundation, as well as the Harvard Program in Therapeutic Science and the Engelberg Foundation.

: JJD, RFB, and ASK report no conflicts of interest.

Document is current